Reviva Pharmaceuticals

RVPH

0.419522.09% ( +0.0759 )

Delay Trading: Nov 10, 14:26:56 (EDT)

Forecast & Rating2 analysts currently cover Reviva Pharmaceuticals, of which 1 give a positive rating. The average price target is $17.50, about 4071.6% upside from the current price of $0.42. Coverage is limited, so the data is for reference only. Data as of Aug 21, 2026; this does not constitute investment advice.

Aug 17, 2026

Price forecast

$17.504071.63%

Forecast & RatingStrong buy

1analysts

Forecast dateNov 9, 2026

Forecast met0.0%

Stock price$0.42

Avg. target$17.5

High target$30

Low target$5

Strong buy

Buy

Hold

Sell

Strong sell

Source: S&P Global

This information is for reference only and is not investment advice.